| 2020 | SCI, SCIE, SSCI, A&HCI
| The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD) Authors/Task Force Members: Francesco Cosentino* (ESC Chairperson) (Sweden), Peter J. Grant* (EASD Chairperson) (United Kingdom), Victor Aboyans (France), Clifford J. Bailey1 (United Kingdom), Antonio Ceriello1 (Italy), Victoria Delgado (Netherlands), Massimo Federici1 (Italy), Gerasimos Filippatos (Greece), Diederick E. Grobbee (Netherlands), Tina Birgitte Hansen (Denmark), Heikki V. Huikuri (Finland), Isabelle Johansson (Sweden), Peter Ju¨ni (Canada), Maddalena Lettino (Italy), Nikolaus Marx (Germany), Linda G. Mellbin (Sweden), Carl J. Ostgren (Sweden), Bianca Rocca (Italy), Marco Roffi (Switzerland), € Naveed Sattar1 (United Kingdom), Petar M. Seferovic (Serbia), Miguel Sousa-Uva (Portugal), Paul Valensi (France), and David C. Wheeler1 (United Kingdom) | 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD | European Heart Journal |
| 2020 | SCI, SCIE, SSCI, A&HCI
| The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Authors/Task Force Members: Franc¸ois Mach* (Chairperson) (Switzerland), Colin Baigent* (Chairperson) (United Kingdom), Alberico L. Catapano1 * (Chairperson) (Italy), Konstantinos C. Koskinas (Switzerland), Manuela Casula1 (Italy), Lina Badimon (Spain), M. John Chapman1 (France), Guy G. De Backer (Belgium), Victoria Delgado (Netherlands), Brian A. Ference (United Kingdom), Ian M. Graham (Ireland), Alison Halliday (United Kingdom), Ulf Landmesser (Germany), Borislava Mihaylova (United Kingdom), Terje R. Pedersen (Norway), Gabriele Riccardi1 (Italy), Dimitrios J. Richter (Greece), Marc S. Sabatine (United States of America), Marja-Riitta Taskinen1 (Finland), Lale Tokgozoglu1 (Turkey), Olov Wiklund1 (Sweden) | 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk | European Heart Journal |
| 2020 | SCI, SCIE, SSCI, A&HCI
| Adam Timmis (Chair Writing Group), Nick Townsend, Chris P. Gale, Aleksandra Torbica, Maddalena Lettino, Steffen E. Petersen, Elias A. Mossialos, Aldo P. Maggioni, Dzianis Kazakiewicz, Heidi T. May , Delphine De Smedt, Marcus Flather, Liesl Zuhlke, John F. Beltrame, Radu Huculeci, Luigi Tavazzi, Gerhard Hindricks, Jeroen Bax, Barbara Casadei, Stephan Achenbach, Lucy Wright and Panos Vardas | European Society of Cardiology: Cardiovascular Disease Statistics 2019 | European Heart Journal |
| 2019 | SCI, SCIE, SSCI, A&HCI
| Authors/Task Force Members (François Macha,∗,2 , Colin Baigentb,∗∗,2 , Alberico L. Catapanoc,∗∗∗,1,2 , Konstantinos C. Koskinasd , Manuela Casulae,f,1 , Lina Badimong , M. John Chapmanh,i,cm,1 , Guy G. De Backerj , Victoria Delgadok , Brian A. Ferencel , Ian M. Grahamm, Alison Hallidayn , Ulf Landmessero,p,q , Borislava Mihaylovar,s , Terje R. Pedersent , Gabriele Riccardiu,1 , Dimitrios J. Richterv , Marc S. Sabatinew, Marja-Riitta Taskinenx,1 , Lale Tokgozogluy,1 , Olov Wiklundz ), ESC National Cardiac Societies (Djamaleddine Nibouchean, Parounak H. Zelveianao, Peter Siostrzonekap, Ruslan Najafovaq, Philippe van de Bornear, Belma Pojskicas, Arman Postadzhiyanat, Lambros Kyprisau, Jindřich Špinarav, Mogens Lytken Larsenaw, Hesham Salah Eldinax, Margus Viigimaaay, Timo E. Strandbergaz, Jean Ferrièresba, Rusudan Agladzebb, Ulrich Laufsbc, Loukianos Rallidisbd, László Bajnokbe, Thorbjörn Gudjónssonbf, Vincent Maherbg, Yaakov Henkinbh, Michele Massimo Guliziabi, Aisulu Mussagaliyevabj, Gani Bajraktaribk, Alina Kerimkulovabl, Gustavs Latkovskisbm, Omar Hamouibn, Rimvydas Slapikasbo, Laurent Visserbp, Philip Dinglibq, Victoria Ivanovbr, Aneta Boskovicbs, Mbarek Nazzibt, Frank Visserenbu, Irena Mitevskabv, Kjetil Retterstølbw, Piotr Jankowskibx, Ricardo Fontes-Carvalhoby, Dan Gaitabz, Marat Ezhovca, Marina Foscolicb, Vojislav Gigacc, Daniel Pellacd, Zlatko Frasce, Leopoldo Perez de Islacf, Emil Hagströmcg, Roger Lehmannch, Leila Abidci, Oner Ozdogancj, Olena Mitchenkock, Riyaz S. Patelcl), ESC Committee for Practice Guidelines (CPG) (Stephan Windeckeraa, Victor Aboyansab, Colin Baigentac, Jean-Philippe Colletab, Veronica Deanab, Victoria Delgadoad, Donna Fitzsimonsac, Chris P. Galeac, Diederick Grobbeead, Sigrun Halvorsenae, Gerhard Hindricksaf, Bernard Iungab, Peter Jüniag, Hugo A. Katusaf, Ulf Landmesseraf, Christophe Leclercqab, Maddalena Lettinoah, Basil S. Lewisai, Bela Merkelyaj, Christian Muelleraa, Steffen Petersenac, Anna Sonia Petronioah, Dimitrios J. Richterak, Marco Roffiaa, Evgeny Shlyakhtoal, Iain A. Simpsonac, Miguel Sousa-Uvaam, Rhian M. Touyzac) | 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk | Atherosclerosis |
| 2017 | SCI, SCIE, SSCI, A&HCI
| Vukmirović M, Bošković A, Tomašević Vukmirović I, Vujadinovic R, Fatić N, Bukumirić Z, Vukmirović F | Predictions and Outcomes of Atrial Fibrillation in the Patients with Acute Myocardial Infarction | Open medicine |
| 2017 | SCI, SCIE, SSCI, A&HCI
| Vukmirović Mihailo, Bošković Aneta, Bukumirić Zoran, Tomašević-Vukmirović Irena, Vukmirović Filip | Predictors and outcomes of new-onset atrial fibrillation in patients with acute myocardial infarction | Vojnosanitetski pregled |
| 2016 | SCI, SCIE, SSCI, A&HCI
| Snežana Mugoša, Nataša Djordjević, Nina Djukanović, Dragana Protić, Zoran Bukumirić, Ivan Radosavljević, Aneta Bošković, Zoran Todorović | Factors affecting the development of adverse drug reactions to β-blockers in hospitalized cardiac patient population | Patient Preference and Adherence |
| 2015 | SCI, SCIE, SSCI, A&HCI
| Snežana Mugoša, Zoran Bukumirić, Aleksandra Kovačević, Aneta Bošković, Dragana Protić, Zoran Todorović | Adverse drug reactions in hospitalized cardiac patients: characteristics and risk factors | Vojnosanitetski pregled |
| 2014 | SCI, SCIE, SSCI, A&HCI
| Bošković, A., Belada, N. & Knežević, B. | Prognostic value of heart rate variability in post-infarction patients | Vojnosanitetski pregled |
| 2010 | SCI, SCIE, SSCI, A&HCI
| Mugosa S, Todorovic Z, Boskovic A, Duborija-Kovacevic N | Focused conference group: P13 - Maximising benefits and minimizing harms from drugs spontaneous reporting of adverse drug reactions and level of intervention: Paper No: 2105 | Basic & Clinical Pharmacology & Toxicology |
| 2009 | SCI, SCIE, SSCI, A&HCI
| B Knežević, N Bulatović, N Belada, V Ivanović, S Dragnić, M Rabrenović G Nikolić, L Musić, A Bošković | Survival benefit of the late percutaneous coronary intervention in the patients after acute myocardial infarction who are or who are not treated with thrombolysis | Bosnian Journal of Basic Medical Sciences |
| 2008 | SCI, SCIE, SSCI, A&HCI
| B. Knežević, G, Nikolić S. Dragnić, Lj. Musić, A. Bošković | Successful treatment of cardiogenic shock bz stenting of the left main coronary artery in acute myocardial infarction | Vojnosanitetski Pregled |
